Sexual Dysfunction in Psychiatric Practice – A Review
Keywords:
mental illness, psychiatric disorders, sexual function, sexual dysfunction, psychotropicsAbstract
Background: Sexual function is considered an important part of human experience and a determining factor of quality of life. With this in mind, sexual dysfunction (SD) affecting a significant percentage of patients in psychiatry has been a subject that has worried those who are concerned not only with the physical well-being but also with the psychological and emotional well-being of their patients.
Aims: To analyze the association between SD and major psychiatric diseases, such as the various components of sexual function that may be altered in these patients and their possible causes, and finally investigate the different approaches to SD in psychiatric practice.
Methods: Non-systematic review through literature research in PubMed/Medline database, using the key-words: “mental disorders”, “psychiatric disorders”, “sexual disorders”, “sexual dysfunction”, “psychotropics”, “antidepressants” and “antipsychotics”. The articles were selected according to their relevance to the topic.
Results: According to the scientific literature, SD is more frequent in individuals with mental illness compared to the general population, affecting 30-60% of patients being treated with antipsychotics for schizophrenia, 70% of patients receiving antidepressants for treatment of depression and up to 80% of individuals suffering from anxious disorders. Sexual problems often associated with psychiatric illness and its treatment include decreased sexual desire, difficulties in arousal, difficulty in achieving orgasm or anorgasmia in females, and erectile dysfunction and problems with ejaculation in males. Studies indicate that SD present in these patients may be due not only to interpersonal relationships and the environment involving them, but also to the influence of psychopathology on sexual function and the action of psychotropic drugs chosen for treatment. SD associated with psychotropic drugs has also as a serious consequence the reduction of therapeutic adherence or even the total abandonment of psychiatric follow-up.
Conclusions: SD has a significant impact on the mental health and quality of life of many patients with psychiatric illness. It is therefore essential that the clinician is aware of this phenomenon and its possible implications, taking an informed attitude and opting for the most appropriate approach. This approach will avoid, or at least mitigate, the impact of mental illness and psychotropic drugs on sexual function and thus ensure good therapeutic adherence and an improvement in the quality of life of these patients.
Downloads
Published
Issue
Section
License
Articles are published under the license CC-BY-3.0 by Creative Commons, in full open-access, without any cost or fees of any kind to the author or the reader. In this scheme, the authors retain copyright and grant the journal right of first publication, allowing the free sharing of work, provided it is correctly attributed the authorship and initial publication in this journal. Readers and end-users are allowed to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship. The authors are permitted to take on additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, post it to an institutional repository or as a book), with an acknowledgment of its initial publication in this journal. Authors are permitted and encouraged to publish and distribute their work online (eg, in institutional repositories or on their website) as it can lead to productive exchanges, as well as increase the impact and citation of published work.
